Briefing: Asian Energy Stocks Surge, Mirroring Oil Prices as Mideast Conflict Grows
Strategic angle: MarketWatch reports on the rise of Asian energy stocks in response to escalating oil prices amid regional tensions.
Editorial Staff Mar 9
Markets
Latest Markets stories from Money.
Strategic view: The Middle East War Is Crushing This Group of Stocks
Strategic implications in focus: The ongoing conflict in the Middle East is significantly impacting certain stock sectors.
Editorial Staff Mar 8
Robinhood targets wealthy customers with new Platinum credit card
Robinhood aims to attract affluent clients with its latest financial product.
editorial-bot Mar 8
Escalating Strikes in Gulf Region: A Strategic Risk Assessment
As U.S.-Israeli operations against Iran escalate, Bahrain and the UAE report increased strikes on civilian targets, highlighting significant geopolitical risks in the region.
Editorial Staff Mar 8
Strategic view: Dow Jones Futures Await Oil Prices' Next Move. Iran Rejects Calls For Cease-Fire.
Strategic implications in focus: Market analysts are closely monitoring oil prices as geopolitical tensions rise.
Editorial Staff Mar 8
Strategic view: 2 No-Brainer Dividend Stocks to Buy in 2026
Strategic implications in focus: Discover two dividend stocks that are poised for growth in 2026.
Editorial Staff Mar 8
Strategic view: Bank of America resets Amazon stock forecast
Strategic implications in focus: Bank of America revises its outlook on Amazon's stock performance.
Editorial Staff Mar 8
Strategic view: Jim Cramer on Campbell’s Company: “Money Managers Don’t Like to Buy the Stocks of Companies That Are Going to Have Down Years”
Strategic implications in focus: Jim Cramer discusses the challenges faced by Campbell's Company in the stock market.
Editorial Staff Mar 8
Strategic view: Jim Cramer on Howmet Aerospace: “It’s Just in The Sweet Spot”
Strategic implications in focus: Jim Cramer discusses the promising outlook for Howmet Aerospace.
Editorial Staff Mar 8
Strategic view: Jim Cramer on AeroVironment, Inc.: “It’s a Long-time Cramer Fave, But Things Don’t Seem Right Here”
Strategic implications in focus: Jim Cramer expresses concerns about AeroVironment, Inc., despite its long-standing popularity.
Editorial Staff Mar 8
Strategic view: Heatwaves driving recent ‘surge’ in compound drought and heat extremes
Strategic implications in focus: Drought and heatwaves occurring together – known as “compound” events – have surged across the globe.
Editorial Staff Mar 6
Strategic view: FDA's Controversial Actions Against UniQure Raise Political Concerns
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.
Editorial Staff Mar 6
CSF Welcomes New Members Amid Growing Commercial Space Sector
The Commercial Space Federation's recent membership expansion reflects strategic positioning in the evolving commercial space landscape.
Editorial Staff Mar 6
Strategic view: Q&A: What does China’s 15th ‘five-year plan’ mean for climate change?
Strategic implications in focus: China’s leadership has published a draft of its 15th five-year plan setting the strategic direction for climate initiatives.
Editorial Staff Mar 6
NASA's Hygiene Protocols in Microgravity: A Tactical Perspective
NASA astronauts' grooming practices aboard the ISS highlight the complexities of maintaining hygiene in a microgravity environment, impacting overall mission efficacy.
Editorial Staff Mar 6
Cygnus XL Completes Cargo Mission: Implications for NASA's Supply Chain
The successful delivery of over 11,000 pounds of cargo by Cygnus XL highlights Northrop Grumman's operational reliability for NASA's ISS missions.
Editorial Staff Mar 6
Moderna's Strategic Shift Towards Oncology: Implications Ahead
Moderna's pivot to oncology reflects broader trends in biotech, with potential risks and opportunities for investors and stakeholders.
Editorial Staff Mar 6
Robinhood's $658 Million Fund for Retail Investors: A Market Disruption?
Robinhood's public offering of a $658 million private markets fund may reshape retail investment dynamics, but risks and implications warrant scrutiny.
Editorial Staff Mar 6
Strategic view: FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China
Strategic implications in focus: China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded.
Editorial Staff Mar 6
Global Warming Rate Nearly Doubles, Paris Agreement at Risk
The latest findings reveal that the rate of global warming has accelerated significantly since 2015, posing a serious risk to the Paris Agreement's 1.5C target by 2030.
Editorial Staff Mar 6